Ara
Toplam kayıt 9, listelenen: 1-9
Synthesis, characterization and biological evaluation of novel antimony(III) iodide complexes with tetramethylthiourea and N-ethylthiourea
(Elsevier S.A., 2019)
Novel trivalent antimony(III) complexes with tetramethylthiourea (TMTU) and N-ethylthiourea (NETU) were synthesized by the reaction of antimony(III) iodide (SbI3). Antimony(III) iodide complexes of formulae {[SbI2(µ2-I)(TMTU)2]2} ...
Structural architectures and biological properties of main group bismuth(III) iodide complexes with heterocyclic thioamides
(Elsevier S.A., 2019)
A series of mononuclear, dinuclear and polynuclear bismuth(III) iodide complexes (1–5) bearing heterocyclic thioamide ligands, 2-mercapto-3,4,5,6-tetrahydro-pyrimidine (tHPMT), 2-mercapto-benzimidazole (MBZIM), ...
QSAR studies on antimony(III) halide complexes with N-substituted thiourea derivatives
(Pergamon-Elsevier Science Ltd, 2017)
The synthesis, characterization and biological studies of three novel antimony(III) complexes (SbX3, X = Cl and Br) with N-substituted thioureas; N,N-dimethylthiourea (DMTU) and N,N-diethylthiourea (DETU) of formulae ...
New antimony(III) halide complexes with dithiocarbamate ligands derived from thiuram degradation: the effect of the molecule's close contacts on in vitro cytotoxic activity
(Elsevier, 2016)
Antimony(III) halide complexes of the formulae {[SbBr(Me2DTC)(2)](n)} (1), {[SbI(Me2DTC)(2)](n)} (2) and {[(Me2DTC)(2)Sb(mu(2)-I)Sb(Me2DTC)(2)](+)center dot I-3(-)} (3) (Me2DTC = dimethyldithiocarbomate) were synthesized ...
Addition of tetraethylthiuram disulfide to antimony(III) iodide; synthesis, characterization and biological activity
(Elsevier Science Sa, 2016)
Three new antimony(III) iodide complexes with the N,N-diethylcarbamodithioic acid of formulae {[(SbI(Et2DTC)(2))(I-2)](n)} (1), {[(Sb(Et2DTC)(2))(4) (SbI6) (I-3)](n)} (2) and {[SbI(Et2DTC)(2)](2)} (3), (Et2DTCH: ...
Synthesis, structural characterization and cytotoxicity of the antimony(III) chloride complex with N,N-dicyclohexyldithiooxamide
(Pergamon-Elsevier Science Ltd, 2013)
The reaction of antimony(III) chloride with the bidentate substituted dithiooxamide ligand, N,N-dicyclohexyldithiooxamide (HDTOA), in 1:1 molar ratio, leads to the formation of the polymeric complex {[SbCl3(HDTOA)(1.5)]}(n) ...
Synthesis, structural characterization and cytostatic properties of N,N-dicyclohexyldithiooxamide complexes of antimony(III) halides (SbX3, X: Br or I)
(Pergamon-Elsevier Science Ltd, 2014)
The novel antimony(III) halide complexes with the bi-dentate substituted dithiooxamide ligand, N,N-dicyclohexyldithiooxamide (HDTOA) of formulae {[SbBr3(HDTOA)(1.5)]}(n) (I) and ([SbI3(HDTOA)(1.5)]center dot C6H6}(n) (2), ...
Synthesis, characterization and biological activity of antimony(III) or bismuth(III) chloride complexes with dithiocarbamate ligands derived from thiuram degradation
(Pergamon-Elsevier Science Ltd, 2014)
Antimony(III) or bismuth(III) complexes of formulae {[SbCI(Me2DTC)(2)](n)} (I), {[BiCl(Me2DTC)(2)](n)} (2) and {[Bi(Et2DTC)(3)](2)} (3) (Me2DTCH = dimethyldithiocarbamate, C3H7NS2 and Et2DTCH = diethyldithiocarbamate, ...
Recent advances on antimony(III/V) compounds with potential activity against tumor cells
(Elsevier Science Inc, 2015)
Antimony one of the heavier pnictogens, has been in medical use against microbes and parasites as well. Antimony-based drugs have been prescribed against leishmaniasis since the parasitic transmission of the tropical disease ...